Telomir Pharmaceuticals, Inc.

SecurityTELO / Telomir Pharmaceuticals, Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership289,198 shares
Latest Disclosed Value $ 375,958
BlackRock, Inc. reports 1.31% increase in ownership of TELO / Telomir Pharmaceuticals, Inc.

On May 13, 2026 - BlackRock, Inc. filed a 13F-HR form disclosing ownership of 289,198 shares of Telomir Pharmaceuticals, Inc. (US:TELO) valued at $375,957 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 285,454 shares of Telomir Pharmaceuticals, Inc.. This represents a change in shares of 1.31% during the quarter. The current value of the position is $367,281 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F TELOMIR PHARMACEUTICALS COM 87975F104 289,198 3,744 1.31 376 -1.06 0.0000
2026-02-12 2025-12-31 13F TELOMIR PHARMACEUTICALS COM 87975F104 285,454 -5,979 -2.05 380 -6.42 0.0000
2025-11-12 2025-09-30 13F TELOMIR PHARMACEUTICALS COM 87975F104 291,433 -78,643 -21.25 405 -12.34 0.0000
2025-08-12 2025-06-30 13F TELOMIR PHARMACEUTICALS COM 87975F104 370,076 -830,485 -69.17 463 -88.08 0.0000
2025-05-02 2025-03-31 13F TELOMIR PHARMACEUTICALS COM 87975F104 1,200,561 143,586 13.58 3,878 -10.96 0.0001
2025-02-07 2024-12-31 13F TELOMIR PHARMACEUTICALS COM 87975F104 1,056,975 690,097 188.10 4,355 84.88 0.0001
2024-11-13 2024-09-30 13F TELOMIR PHARMACEUTICALS COM 87975F104 366,878 278,979 317.39 2,355 458.06 0.0000
2024-08-13 2024-06-30 13F TELOMIR PHARMACEUTICALS COM 87975F104 87,899 87,899 423 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.